S
Sangamo Therapeutics
Brisbane, United States
Founded 1995 NASDAQ: SGMO
Gene Therapy Delivery Nano-Bio DNA Nanotechnology Protein Engineering Cell Therapy Nano Nanomedicine
About
Zinc finger nuclease gene editing and gene regulation
Company Details
- Type
- public
- Employees
- 300+
- Funding
- Public
Key Products
- ZFN Technology
- Gene Therapy